Cetera Investment Advisers’s Terns Pharmaceuticals TERN Stock Holding History

Cetera Investment Advisers’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,894	Closed	-$205K	–	5154
2026 Q1	$205K	Buy	+3,894	New	+$160K	﹤0.01%	4270

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cetera Investment Advisers's TERN Position: Q2 2026 in Review

Cetera Investment Advisers sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 3,894 shares — an estimated $205K sold.

Cetera Investment Advisers first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $205K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Cetera Investment Advisers reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Cetera Investment Advisers sold 3,894 Terns Pharmaceuticals shares in Q2 2026, an estimated $205K.
Cetera Investment Advisers first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Cetera Investment Advisers's Terns Pharmaceuticals position peaked at $205K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.